Study In Patients With Insulin Resistance
NCT00197132
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Insulin Resistance
Interventions
DRUG:
Avandia
Sponsor
GlaxoSmithKline